Hologic, Inc. (HOLX) Holdings Lifted by Cipher Capital LP

Cipher Capital LP raised its stake in Hologic, Inc. (NASDAQ:HOLX) by 57.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 117,673 shares of the medical equipment provider’s stock after buying an additional 43,146 shares during the quarter. Cipher Capital LP’s holdings in Hologic were worth $4,317,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. SG Americas Securities LLC increased its stake in Hologic by 107.6% during the third quarter. SG Americas Securities LLC now owns 34,916 shares of the medical equipment provider’s stock worth $1,281,000 after purchasing an additional 18,096 shares during the period. RKL Wealth Management LLC increased its stake in Hologic by 21.6% during the third quarter. RKL Wealth Management LLC now owns 23,885 shares of the medical equipment provider’s stock worth $875,000 after purchasing an additional 4,250 shares during the period. Thompson Investment Management Inc. increased its stake in Hologic by 3.6% during the third quarter. Thompson Investment Management Inc. now owns 78,923 shares of the medical equipment provider’s stock worth $2,896,000 after purchasing an additional 2,764 shares during the period. Advisors Asset Management Inc. increased its stake in Hologic by 9.3% during the third quarter. Advisors Asset Management Inc. now owns 18,140 shares of the medical equipment provider’s stock worth $666,000 after purchasing an additional 1,538 shares during the period. Finally, Quantbot Technologies LP increased its stake in Hologic by 3,975.5% during the third quarter. Quantbot Technologies LP now owns 288,140 shares of the medical equipment provider’s stock worth $10,571,000 after purchasing an additional 281,070 shares during the period. 96.41% of the stock is currently owned by institutional investors.

WARNING: “Hologic, Inc. (HOLX) Holdings Lifted by Cipher Capital LP” was published by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://transcriptdaily.com/2017/11/18/hologic-inc-holx-holdings-lifted-by-cipher-capital-lp.html.

A number of analysts have issued reports on HOLX shares. Bank of America Corporation reiterated a “neutral” rating and set a $48.00 price target (up from $44.00) on shares of Hologic in a research note on Friday, July 21st. BidaskClub lowered shares of Hologic from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Needham & Company LLC reiterated a “buy” rating on shares of Hologic in a research note on Tuesday, August 1st. Royal Bank Of Canada cut their price target on shares of Hologic from $50.00 to $45.00 and set a “sector perform” rating on the stock in a research note on Thursday, August 3rd. Finally, The Goldman Sachs Group, Inc. lowered shares of Hologic from a “conviction-buy” rating to a “buy” rating and cut their price target for the stock from $48.00 to $47.00 in a research note on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the stock. Hologic currently has a consensus rating of “Buy” and a consensus target price of $47.54.

In other Hologic news, Director Lawrence M. Levy sold 7,139 shares of the stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $39.04, for a total value of $278,706.56. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Lawrence M. Levy sold 9,596 shares of the stock in a transaction that occurred on Tuesday, October 10th. The shares were sold at an average price of $36.81, for a total transaction of $353,228.76. The disclosure for this sale can be found here. Insiders sold 34,949 shares of company stock worth $1,345,220 over the last quarter. 0.79% of the stock is currently owned by insiders.

Shares of Hologic, Inc. (NASDAQ HOLX) traded up $0.24 during trading on Friday, reaching $39.96. 2,085,108 shares of the company’s stock traded hands, compared to its average volume of 2,739,979. The stock has a market capitalization of $11,140.00, a price-to-earnings ratio of 19.61, a P/E/G ratio of 1.92 and a beta of 0.93. Hologic, Inc. has a one year low of $35.76 and a one year high of $46.80. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.79 and a quick ratio of 0.61.

Hologic (NASDAQ:HOLX) last announced its quarterly earnings results on Wednesday, November 8th. The medical equipment provider reported $0.50 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.49 by $0.01. The company had revenue of $802.90 million for the quarter, compared to analyst estimates of $792.54 million. Hologic had a net margin of 24.70% and a return on equity of 21.69%. The firm’s revenue was up 10.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.52 earnings per share. sell-side analysts predict that Hologic, Inc. will post 2.12 earnings per share for the current year.

Hologic Company Profile

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply